S
3.15
0.03 (0.96%)
| Previous Close | 3.12 |
| Open | 3.12 |
| Volume | 202,558 |
| Avg. Volume (3M) | 719,192 |
| Market Cap | 226,326,592 |
| Price / Earnings (Forward) | 2.94 |
| Price / Sales | 4.27 |
| Price / Book | 1.38 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| TTM Dividend Yield | 19.05% |
| Profit Margin | 40.33% |
| Operating Margin (TTM) | -32.03% |
| Diluted EPS (TTM) | 0.670 |
| Quarterly Revenue Growth (YOY) | -72.30% |
| Quarterly Earnings Growth (YOY) | -36.70% |
| Total Debt/Equity (MRQ) | 0.56% |
| Current Ratio (MRQ) | 8.40 |
| Operating Cash Flow (TTM) | 61.94 M |
| Levered Free Cash Flow (TTM) | 4.77 M |
| Return on Assets (TTM) | 14.40% |
| Return on Equity (TTM) | 25.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | SIGA Technologies Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | 4.5 |
| Macro Environment | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 0.64 |
Select this tab to load the latest available analysis.
|
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 43.34% |
| % Held by Institutions | 51.60% |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 19.05% |
| 4Y Average Dividend Yield | 8.49% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 07 Apr 2026 | - | 23 Apr 2026 | 0.6 Cash |
| 29 Apr 2025 | 08 Apr 2025 | 15 May 2025 | 0.6 Cash |
| 25 Mar 2024 | 12 Mar 2024 | 11 Apr 2024 | 0.6 Cash |
| 15 May 2023 | - | 01 Jun 2023 | 0.45 Cash |
| 16 May 2022 | - | 02 Jun 2022 | 0.45 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.600 | 1 | 19.05 |
| 2025 | 0.600 | 1 | 9.82 |
| 2024 | 0.600 | 1 | 9.98 |
| 2023 | 0.450 | 1 | 8.04 |
| 2022 | 0.450 | 1 | 6.11 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |